-
Something wrong with this record ?
Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver
Ľ. Pašková, V. Kuncírová, S. Poništ, D. Mihálová, R. Nosáľ, J. Harmatha, I. Hrádková, T. Čavojský, F. Bilka, K. Šišková, I. Paulíková, L. Bezáková, K. Bauerová,
Language English Country Egypt
Document type Journal Article
NLK
Directory of Open Access Journals
from 1990
Free Medical Journals
from 2014
PubMed Central
from 2014
Europe PubMed Central
from 2014
ProQuest Central
from 2008-01-01
Open Access Digital Library
from 1990-01-01
Open Access Digital Library
from 2014-01-08
Open Access Digital Library
from 2014-01-01
Medline Complete (EBSCOhost)
from 2014-01-01
Health & Medicine (ProQuest)
from 2008-01-01
Wiley-Blackwell Open Access Titles
from 1990
ROAD: Directory of Open Access Scholarly Resources
from 2014
PubMed
27556049
DOI
10.1155/2016/7509653
Knihovny.cz E-resources
- MeSH
- Arachidonate Lipoxygenases genetics metabolism MeSH
- Arthritis, Experimental drug therapy genetics pathology MeSH
- Biomarkers MeSH
- C-Reactive Protein MeSH
- Time Factors MeSH
- Cytokines blood genetics metabolism MeSH
- Liver drug effects metabolism MeSH
- Rats MeSH
- Inflammation Mediators * MeSH
- Methotrexate pharmacology MeSH
- Disease Models, Animal MeSH
- Organ Specificity MeSH
- Gene Expression Regulation drug effects MeSH
- Serotonin analogs & derivatives pharmacology MeSH
- Severity of Illness Index MeSH
- Transcriptome * MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Rheumatoid arthritis (RA) is a chronic inflammatory disease, leading to progressive destruction of joints and extra-articular tissues, including organs such as liver and spleen. The purpose of this study was to compare the effects of a potential immunomodulator, natural polyphenol N-feruloylserotonin (N-f-5HT), with methotrexate (MTX), the standard in RA therapy, in the chronic phase of adjuvant-induced arthritis (AA) in male Lewis rats. The experiment included healthy controls (CO), arthritic animals (AA), AA given N-f-5HT (AA-N-f-5HT), and AA given MTX (AA-MTX). N-f-5HT did not affect the body weight change and clinical parameters until the 14th experimental day. Its positive effect was rising during the 28-day experiment, indicating a delayed onset of N-f-5HT action. Administration of either N-f-5HT or MTX caused reduction of inflammation measured as the level of CRP in plasma and the activity of LOX in the liver. mRNA transcription of TNF-α and iNOS in the liver was significantly attenuated in both MTX and N-f-5HT treated groups of arthritic rats. Interestingly, in contrast to MTX, N-f-5HT significantly lowered the level of IL-1β in plasma and IL-1β mRNA expression in the liver and spleen of arthritic rats. This speaks for future investigations of N-f-5HT as an agent in the treatment of RA in combination therapy with MTX.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013574
- 003
- CZ-PrNML
- 005
- 20240312143739.0
- 007
- ta
- 008
- 170413e20160731ua f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2016/7509653 $2 doi
- 035 __
- $a (PubMed)27556049
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ua
- 100 1_
- $a Pašková, Ľudmila $u Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia.
- 245 10
- $a Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver / $c Ľ. Pašková, V. Kuncírová, S. Poništ, D. Mihálová, R. Nosáľ, J. Harmatha, I. Hrádková, T. Čavojský, F. Bilka, K. Šišková, I. Paulíková, L. Bezáková, K. Bauerová,
- 520 9_
- $a Rheumatoid arthritis (RA) is a chronic inflammatory disease, leading to progressive destruction of joints and extra-articular tissues, including organs such as liver and spleen. The purpose of this study was to compare the effects of a potential immunomodulator, natural polyphenol N-feruloylserotonin (N-f-5HT), with methotrexate (MTX), the standard in RA therapy, in the chronic phase of adjuvant-induced arthritis (AA) in male Lewis rats. The experiment included healthy controls (CO), arthritic animals (AA), AA given N-f-5HT (AA-N-f-5HT), and AA given MTX (AA-MTX). N-f-5HT did not affect the body weight change and clinical parameters until the 14th experimental day. Its positive effect was rising during the 28-day experiment, indicating a delayed onset of N-f-5HT action. Administration of either N-f-5HT or MTX caused reduction of inflammation measured as the level of CRP in plasma and the activity of LOX in the liver. mRNA transcription of TNF-α and iNOS in the liver was significantly attenuated in both MTX and N-f-5HT treated groups of arthritic rats. Interestingly, in contrast to MTX, N-f-5HT significantly lowered the level of IL-1β in plasma and IL-1β mRNA expression in the liver and spleen of arthritic rats. This speaks for future investigations of N-f-5HT as an agent in the treatment of RA in combination therapy with MTX.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a arachidonátlipoxygenasy $x genetika $x metabolismus $7 D001091
- 650 _2
- $a artritida experimentální $x farmakoterapie $x genetika $x patologie $7 D001169
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a C-reaktivní protein $7 D002097
- 650 _2
- $a cytokiny $x krev $x genetika $x metabolismus $7 D016207
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a regulace genové exprese $x účinky léků $7 D005786
- 650 12
- $a mediátory zánětu $7 D018836
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methotrexát $x farmakologie $7 D008727
- 650 _2
- $a orgánová specificita $7 D009928
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a serotonin $x analogy a deriváty $x farmakologie $7 D012701
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a časové faktory $7 D013997
- 650 12
- $a transkriptom $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kuncírová, Viera $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
- 700 1_
- $a Poništ, Silvester $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
- 700 1_
- $a Mihálová, Danica $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
- 700 1_
- $a Nosáľ, Radomír $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
- 700 1_
- $a Harmatha, Juraj $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 166 10 Prague, Czech Republic.
- 700 1_
- $a Hrádková, Iveta $u Faculty of Food and Biochemical Technology, University of Chemistry and Technology, 166 28 Prague, Czech Republic.
- 700 1_
- $a Čavojský, Tomáš $u Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia.
- 700 1_
- $a Bilka, František $u Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia.
- 700 1_
- $a Šišková, Katarína $u Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia. $7 xx0222712
- 700 1_
- $a Paulíková, Ingrid $u Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia.
- 700 1_
- $a Bezáková, Lýdia $u Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia.
- 700 1_
- $a Bauerová, Katarína, $d 1961- $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia; Department of Galenic Pharmacy, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia. $7 xx0267301
- 773 0_
- $w MED00186351 $t Journal of immunology research $x 2314-7156 $g Roč. 2016 (20160731), s. 7509653
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27556049 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20240312143735 $b ABA008
- 999 __
- $a ok $b bmc $g 1200039 $s 974352
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 2016 $c - $d 7509653 $e 20160731 $i 2314-7156 $m Journal of immunology research $n J. immunol. res. $x MED00186351
- LZP __
- $a Pubmed-20170413